Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 4 Incremental cost-effectiveness ratio (ICER) both overall and for subgroups based on Medicare costs and both Framingham and Saskatchewan life expectancy estimates. *ICER in women considering life expectancy gains due to the prevention of cardiovascular death rather than all-cause death (in addition to nonfatal stroke and myocardial infarction [MI]): $29,130 on the basis of Framingham; $49,369 on the basis of Saskatchewan. LYG = life-year gained.
|
